Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

NCT01939834 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Subjects preferred the 5 night overnight system in terms of ease of use.

Conditions

Type 1 Diabetes Mellitus

Interventions

DEVICE: Overnight CLC
DEVICE: Sensor-Augmented Pump Therapy (SAP)

Sponsor

Sue Brown

Collaborators

[object Object]
[object Object]